Cheng-Ze Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cheng-Ze Chen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bang-Yi Lin
Department of Surgical Oncology The First Affiliated Hospital of Wenzhou Medical University Wenzhou China
2 shared publications - Jialiang Wen
Department of Thyroid and Breast Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou PR China
2 shared publications - Jinmiao Qu
Department of thyroid surgery, the first affiliated hospital of Wenzhou Medical University, Wenzhou, 325035, China
2 shared publications Chen Zheng
Department of Thyroid & Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, PR China
1 shared publication- Chen Zheng
Department of Surgical Oncology The First Affiliated Hospital of Wenzhou Medical University Wenzhou China
1 shared publication Li‐Zhi Lin
Department of Surgical Oncology The First Affiliated Hospital of Wenzhou Medical University Wenzhou China
1 shared publication
Latest Publications
- Open Access
- 23 September 2020
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (22) , 13070-13080
Eva‐1 homolog A promotes papillary thyroid cancer progression and epithelial‐mesenchymal transition via the Hippo signalling pathway
Recently, the incidence of thyroid cancer is increasing worldwide. Papillary thyroid cancer (PTC) is the most common histological type of thyroid cancer. Whole‐transcriptome sequence analysis was performed to further understand the primary molecular mechanisms of the occurrence and progression of PTC. Results showed that Eva‐1 homolog A (EVA1A) may be a potential gene for the PTC‐associated gene in thyroid cancer. In this work, the role of EVA1A expression in thyroid cancer was investigated. Real‐time PCR was performed to detect the expression level of EVA1A in 43 pairs of PTC and four thyroid cancer cell lines. The Cancer Genome Atlas (TCGA) database was used to evaluate the relationship between the expression level of EVA1A and the pathological feature of PTC. The logistic regression analysis of the TCGA data set indicated that the expression of EVA1A was an independent risk factor for tumour, nde and metastasis (TNM) in PTC. This study shows the down‐regulation of EVA1A inhibited the colony formation, proliferation, migration and invasion of PTC cell lines. In the protein level, knockdown of EVA1A can regulate the expression of N‐cadherin, vimentin, Bcl‐xL, Bax, YAP and TAZ. This study indicated that EVA1A was an oncogene associated with PTC.
- 23 September 2020
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (22) , 13070-13080
Open AccessEva‐1 homolog A promotes papillary thyroid cancer progression and epithelial‐mesenchymal transition via the Hippo signalling pathway
Recently, the incidence of thyroid cancer is increasing worldwide. Papillary thyroid cancer (PTC) is the most common histological type of thyroid cancer. Whole‐transcriptome sequence analysis was performed to further understand the primary molecular mechanisms of the occurrence and progression of PTC. Results showed that Eva‐1 homolog A (EVA1A) may be a potential gene for the PTC‐associated gene in thyroid cancer. In this work, the role of EVA1A expression in thyroid cancer was investigated. Real‐time PCR was performed to detect the expression level of EVA1A in 43 pairs of PTC and four thyroid cancer cell lines. The Cancer Genome Atlas (TCGA) database was used to evaluate the relationship between the expression level of EVA1A and the pathological feature of PTC. The logistic regression analysis of the TCGA data set indicated that the expression of EVA1A was an independent risk factor for tumour, nde and metastasis (TNM) in PTC. This study shows the down‐regulation of EVA1A inhibited the colony formation, proliferation, migration and invasion of PTC cell lines. In the protein level, knockdown of EVA1A can regulate the expression of N‐cadherin, vimentin, Bcl‐xL, Bax, YAP and TAZ. This study indicated that EVA1A was an oncogene associated with PTC.
- 1 August 2020
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 14 (11) , 969-980
Loc389641 Promotes Papillary Thyroid Cancer Progression by Regulating the Emt Pathway
Aim: Thyroid cancer (TC) is one of the most common types of endocrine malignancy and poses a significant challenge to human health. The long noncoding RNA 389641 (LOC389641) has been found to be as...
- 1 August 2020
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 14 (11) , 969-980
Loc389641 Promotes Papillary Thyroid Cancer Progression by Regulating the Emt Pathway
Aim: Thyroid cancer (TC) is one of the most common types of endocrine malignancy and poses a significant challenge to human health. The long noncoding RNA 389641 (LOC389641) has been found to be as...